Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Nov;38(11):761-6.
doi: 10.1136/jmg.38.11.761.

Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations

Affiliations

Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations

R P Erickson et al. J Med Genet. 2001 Nov.

Abstract

Background: Hereditary lymphoedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphoedema of the limbs, with variable age of onset, and extra aberrant growth of eyelashes from the Meibomian gland (distichiasis). Other major reported complications include cardiac defects, cleft palate, and extradural cysts. Photophobia, exotropia, ptosis, congenital ectropion, and congenital cataracts are additional eye findings. Recently, we reported that truncating mutations in the forkhead transcription family member FOXC2 resulted in LD in two families.

Methods: The clinical findings in seven additional families with LD, including the original family described by Falls and Kertesz, were determined and mutational analyses were performed.

Results: Distichiasis was the most common clinical feature followed by age dependent lymphoedema. There is a wide variation of associated secondary features including tetralogy of Fallot and cleft palate. The mutational analyses identified truncating mutations in all of the families studied (two nonsense, one deletion, three insertion, and one insertion-deletion), which most likely result in haploinsufficiency of FOXC2.

Conclusions: FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Circ Res. 1999 Nov 26;85(11):992-9 - PubMed
    1. Trans Am Ophthalmol Soc. 1964;62:248-75 - PubMed
    1. Nat Genet. 2000 Jun;25(2):153-9 - PubMed
    1. Am J Hum Genet. 2000 Aug;67(2):295-301 - PubMed
    1. Am J Hum Genet. 2000 Dec;67(6):1382-8 - PubMed

Publication types

MeSH terms